IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
62.43
+1.20 (1.95%)
Feb 5, 2025, 11:37 AM EST - Market open
IRADIMED CORPORATION Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for IRADIMED CORPORATION stock has a target of 60, which predicts a decrease of -3.88% from the current stock price of 62.43.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 2, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for IRADIMED CORPORATION is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $65 → $60 | Strong Buy | Maintains | $65 → $60 | -3.88% | Aug 2, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +4.12% | Apr 22, 2024 |
| Roth Capital | Roth Capital | Strong Buy Maintains $32 → $36 | Strong Buy | Maintains | $32 → $36 | -42.33% | Aug 2, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | -74.37% | Oct 31, 2017 |
| Roth Capital | Roth Capital | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Jul 31, 2017 |
Financial Forecast
Revenue This Year
74.48M
from 65.56M
Increased by 13.60%
Revenue Next Year
82.27M
from 74.48M
Increased by 10.46%
EPS This Year
1.69
from 1.35
Increased by 25.42%
EPS Next Year
1.79
from 1.69
Increased by 5.42%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 76.8M | 84.9M | 103.9M |
| Avg | 74.5M | 82.3M | 101.0M |
| Low | 71.5M | 78.9M | 97.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 17.1% | 13.9% | 26.3% |
| Avg | 13.6% | 10.5% | 22.7% |
| Low | 9.0% | 5.9% | 17.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.75 | 1.87 | 2.26 |
| Avg | 1.69 | 1.79 | 2.19 |
| Low | 1.62 | 1.69 | 2.11 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 29.9% | 10.4% | 26.5% |
| Avg | 25.4% | 5.4% | 22.9% |
| Low | 19.8% | -0.4% | 18.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.